Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > DEA/WHITEHOUSE/major announcement this week?!?!
View:
Post by alleyesonme on Feb 06, 2024 4:18pm

DEA/WHITEHOUSE/major announcement this week?!?!

Adrian Snead • 1st
Partner @ Porter Wright Morris & Arthur...
1h • O Big #cannabis announcement is coming from the White
House this week. A highly placed Administration source confirmed that there will be a big announcement regarding cannabis
likely this week. I suspect it will be a rescheduling decision from DEA, but
it could also be something more drastic. Last week, senators Warren (D-MA), Fetterman (D-PA), Schumer (D-NY), Booker (D-N.J.), Jeff Merkley (D-Ore.), Bernie Sanders (I-Vt.), Kirsten Gillibrand (D-N.Y.), Ron Wyden (D-Ore.), John Hickenlooper (D-Colo.), Peter Welch (D-Vt.), Chris Van Hollen (D-Md.), and Alex Padilla (D-Calif.) urged President Biden to swiftly deschedule
marijuana. We will see what the White House and Admin ultimately
decide, likely sooner than later.
Comment by subaru1i on Feb 06, 2024 7:01pm
alleyesonme....thinking before Biden's speech on March 7...broadcast nation wide.   
Comment by subaru1i on Feb 06, 2024 7:03pm
Also...Pfizer is a U.S. corporation....legal and tax implications for them if still on Schedule 1....so hang on because personally I think the FDA already approved the NDA or 505b (2) but is stuck pending DEA.   The FDA CANNOT over rule the DEA simply with their approval because DEA ruling also affects INTERSTATE COMMERCE!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities